Search research articles
Contact Us
Filters
Showing results (141-150 of 172) with videos related to
Page
of 18
Sort By:
The Journal of Arthroplasty
|
October 26, 2024
How Should Vancouver B1-Periprosthetic Fractures at the Tip of a Cemented or Uncemented Femoral Stem Be Treated?
Pablo A Slullitel, Jakob Van Oldenrijk, Shang-Wen Tsai, et al.
Journal for Immunotherapy of Cancer
|
February 17, 2022
CD19-directed chimeric antigen receptor T cell therapy in Waldenström macroglobulinemia: a preclinical model and initial clinical experience
M Lia Palomba, David Qualls, Sebastien Monette, et al.
Blood Cancer Discovery
|
October 22, 2020
Defining an Optimal Dual-Targeted CAR T-cell Therapy Approach Simultaneously Targeting BCMA and GPRC5D to Prevent BCMA Escape-Driven Relapse in Multiple Myeloma
Carlos Fernández de Larrea, Mette Staehr, Andrea V Lopez, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
September 8, 2019
Presalvage International Staging System Stage and Other Important Outcome Associations in CD34<sup>+</sup>-Selected Allogeneic Hematopoietic Stem Cell Transplantation for Multiple Myeloma
Adam R Bryant, Patrick Hilden, Sergio Giralt, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
April 22, 2018
Development and Evaluation of an Optimal Human Single-Chain Variable Fragment-Derived BCMA-Targeted CAR T Cell Vector
Eric L Smith, Mette Staehr, Reed Masakayan, et al.
Cancer Immunology Research
|
May 23, 2019
BCMA-Targeted CAR T-cell Therapy plus Radiotherapy for the Treatment of Refractory Myeloma Reveals Potential Synergy
Eric L Smith, Sham Mailankody, Mette Staehr, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 13, 2022
Capture Rate of V(D)J Sequencing for Minimal Residual Disease Detection in Multiple Myeloma
Malin Hultcrantz, Even H Rustad, Venkata Yellapantula, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
July 27, 2020
Prognostic Factors for Postrelapse Survival after ex Vivo CD34<sup>+</sup>-Selected (T Cell-Depleted) Allogeneic Hematopoietic Cell Transplantation in Multiple Myeloma
Alexandra Gomez-Arteaga, Gunjan L Shah, Raymond E Baser, et al.
Journal for Immunotherapy of Cancer
|
July 15, 2020
The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of multiple myeloma
Nina Shah, Jack Aiello, David E Avigan, et al.
Cell Reports
|
August 23, 2025
Integrative genomic identification of therapeutic targets for pancreatic cancer
Jimmy A Guo, Dennis Gong, Kyle Evans, et al.
Page
of 18
Search research articles
Search
Showing results (141-150 of 172) with videos related to
Sort By:
Page
of 18
The Journal of Arthroplasty
|
October 26, 2024
How Should Vancouver B1-Periprosthetic Fractures at the Tip of a Cemented or Uncemented Femoral Stem Be Treated?
Pablo A Slullitel, Jakob Van Oldenrijk, Shang-Wen Tsai, et al.
Journal for Immunotherapy of Cancer
|
February 17, 2022
CD19-directed chimeric antigen receptor T cell therapy in Waldenström macroglobulinemia: a preclinical model and initial clinical experience
M Lia Palomba, David Qualls, Sebastien Monette, et al.
Blood Cancer Discovery
|
October 22, 2020
Defining an Optimal Dual-Targeted CAR T-cell Therapy Approach Simultaneously Targeting BCMA and GPRC5D to Prevent BCMA Escape-Driven Relapse in Multiple Myeloma
Carlos Fernández de Larrea, Mette Staehr, Andrea V Lopez, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
September 8, 2019
Presalvage International Staging System Stage and Other Important Outcome Associations in CD34<sup>+</sup>-Selected Allogeneic Hematopoietic Stem Cell Transplantation for Multiple Myeloma
Adam R Bryant, Patrick Hilden, Sergio Giralt, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
April 22, 2018
Development and Evaluation of an Optimal Human Single-Chain Variable Fragment-Derived BCMA-Targeted CAR T Cell Vector
Eric L Smith, Mette Staehr, Reed Masakayan, et al.
Cancer Immunology Research
|
May 23, 2019
BCMA-Targeted CAR T-cell Therapy plus Radiotherapy for the Treatment of Refractory Myeloma Reveals Potential Synergy
Eric L Smith, Sham Mailankody, Mette Staehr, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 13, 2022
Capture Rate of V(D)J Sequencing for Minimal Residual Disease Detection in Multiple Myeloma
Malin Hultcrantz, Even H Rustad, Venkata Yellapantula, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
July 27, 2020
Prognostic Factors for Postrelapse Survival after ex Vivo CD34<sup>+</sup>-Selected (T Cell-Depleted) Allogeneic Hematopoietic Cell Transplantation in Multiple Myeloma
Alexandra Gomez-Arteaga, Gunjan L Shah, Raymond E Baser, et al.
Journal for Immunotherapy of Cancer
|
July 15, 2020
The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of multiple myeloma
Nina Shah, Jack Aiello, David E Avigan, et al.
Cell Reports
|
August 23, 2025
Integrative genomic identification of therapeutic targets for pancreatic cancer
Jimmy A Guo, Dennis Gong, Kyle Evans, et al.
Page
of 18